(Q57304425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Benjamin Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Kai-Ping Liao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hoang Nguyen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Daniel R Gomez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Linda S Elting

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

English

0 references

publication date

4 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

1428-1436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Combining molecular therapeutics with radiotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

7 January 2021

Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

7 January 2021

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

7 January 2021

Obstacles to the implementation of antiemetic guidelines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27899

7 January 2021

Identifiers

DOI

10.1002/CNCR.27899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212885%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference